Successful fidaxomicin hospital discharges of adult patients with Clostridioides difficile infections post 2021 guidelines – are economic barriers finally coming down?

Clin Infect Dis. 2021 Dec 31:ciab1061. doi: 10.1093/cid/ciab1061. Online ahead of print.

ABSTRACT

We reviewed C.difficile positive patients discharged on fidaxomicin after local adoption of 2021C.difficile infection (CDI) guidelines. From June 14 - Oct 3, 2021, 80% (12/15) had copayments $0-$35, and 27% (4/15) required prior authorization. The 30-day CDI recurrence was 7%.

PMID:34971358 | DOI:10.1093/cid/ciab1061